Here we showed that CaMKIIδ deletion neither improved the survival pattern nor mitigated adverse myocardial remodeling, as evidenced by echocardiographic, gravimetric, histological, and molecular analyses, suggesting that induced CaMKII activity during early HF transition in long-term VO is secondary to the underlying pathologies. The gene discussed is CAMK2G; the disease is hydrops fetalis.